Reference for REPOTRECTINIB. Search for REPOTRECTINIB

AI searches containing REPOTRECTINIB

REPOTRECTINIB

Repotrectinib

Medication

Repotrectinib, sold under the brand name Augtyro, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is taken by mouth

Repotrectinib

Bristol Myers Squibb

American pharmaceutical company

cash, helping to boost its complement of cancer drugs, specifically repotrectinib. That same month, the company announced it would be investing $180m

Bristol Myers Squibb

Bristol_Myers_Squibb

Elranatamab

Medication

Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Taletrectinib (ROS1)

Elranatamab

Mosunetuzumab

Monoclonal antibody

Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Taletrectinib (ROS1)

Mosunetuzumab

ALK inhibitor

Class of pharmaceutical drugs

for treatment of TrkA-, TrkB-, TrkC-, ROS1- and ALK-positive NSCLC) Repotrectinib (TPX-0005, Turning Point Therapeutics) Envonalkib, approved in China

ALK inhibitor

ALK_inhibitor

ATC code L01

Pharmaceutical drug classification

L01EX25 Umbralisib L01EX26 Sitravatinib L01EX27 Capivasertib L01EX28 Repotrectinib L01EX29 Vimseltinib QL01EX90 Toceranib L01FA01 Rituximab L01FA02 Ofatumumab

ATC code L01

ATC_code_L01

List of drugs granted breakthrough therapy designation

deletions or exon 21 L858R mutations, as detected by an FDA-approved test Repotrectinib Treatment of people aged twelve years of age and older with solid tumors

List of drugs granted breakthrough therapy designation

List_of_drugs_granted_breakthrough_therapy_designation

List of drugs: Re

(INN) Repan reparixin (USAN) Repatha repifermin (INN) repirinast (INN) repotrectinib (INN) repromicin (INN) Repronex reproterol (INN) Requip Resa Resaid

List of drugs: Re

List_of_drugs:_Re